COVID vaccine: ‘Roll up your sleeves’ call to Fife's under 50s
Fifers aged 18-49 are being asked to roll up their sleeves and prepare for their COVID vaccines.
They form the next cohort to be given appointments in the mass vaccination programme.
Over 225,000 jags have already been administered across the Kingdom, and now NHS Fife is gearing up for a major push as it starts on the under-50s.
It has appealed for people to be patient as it issues appointments, and sets up a network of four mass vaccination centres.
Two have been announced - the biggest of them all at the former M&S store in Kirkcaldy’s High Street, and one at Fife College’s Carnegie Conference Centre in Dunfermline.
The aim is for all adults in Scotland to be vaccinated by the end of July, depending on vaccine supply. Those aged 40-49 will be invited first, followed by those 30-39 and then 18-29.
Launching the ‘‘Roll Up Your Sleeves’ call, Scott Garden, director of pharmacy and medicines, Scott Garden, said: “We have made great progress in delivering more than 225,000 doses of the vaccine to people in Fife to date and I am hugely grateful to the vaccine delivery teams for how they have responded to this huge logistical challenge.
“You will be invited when it is your turn to get vaccinated so please be patient as we work through the age groups.
“Please do get the vaccine if you are able to do so. You can get really ill with coronavirus at any age.
“The vaccine provides our best way out of the coronavirus pandemic and a return, in time, to the things we’ve all missed.”
Professor Emma Thomson of the University of Glasgow Virus Research, an expert in infectious diseases, who led work undertaken in Scotland to develop the vaccine, added: “Each vaccine passes through a three-phase testing process, reviewed by independent regulatory and advisory bodies, to ensure it is effective and safe.
“Licensed COVID-19 vaccines have passed through the same rigorous tests as all other vaccines in tens of thousands of participants who have taken part in trials around the world, and we continue to monitor for side-effects even after licensing in the millions of people who have already received the vaccine.”